# Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects

> **NCT01407393** · PHASE4 · COMPLETED · sponsor: **InQpharm Group** · enrollment: 124 (actual)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DEVICE:** Glucosanol
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT01407393
- **Lead sponsor:** InQpharm Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2013-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01407393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01407393, "Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01407393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*